Nephroprotective effect of apilarnil in lipopolysaccharide-induced sepsis through TLR4/NF-κB signaling pathway.
Apilarnil
Inflammation
Kidney
LPS
Sepsis
Journal
Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521
Informations de publication
Date de publication:
01 Nov 2021
01 Nov 2021
Historique:
received:
28
03
2021
revised:
26
07
2021
accepted:
05
08
2021
pubmed:
14
8
2021
medline:
8
10
2021
entrez:
13
8
2021
Statut:
ppublish
Résumé
In this study, we aimed to investigate the protective effect of apilarnil on kidney damage in the sepsis model induced by LPS. 64 Sprague Dawley adult male rats were randomly divided into eight groups; control group, groups in which 0.2, 0.4 and 0.8 g/kg/bw apilarnil (API) was applied by oral gavage method for 10 days, LPS group in which 30 mg/kg/bw lipopolysaccharide (LPS) administered as intraperitoneally, groups in which LPS + 0.2, LPS+ 0.4 and LPS +0,8 API was applied. Six hour after the last administration the rats were anesthetized for euthanasia and kidney tissues were removed for RT-PCR analysis, immunohistochemical analysis and histopathologic analysis. According to the results of RT-PCR expression levels of IL-6, IL-1β, NF-κB, TNF-α and TLR4 were significantly reduced in the LPS + 0,8 API group. Immunoreactivity of TLR4, pNF-κB and TNF-α levels in the LPS + 0.8 apilarnil group were significantly lower than in the LPS and LPS + 0.2 apilarnil groups. Histologically, compared to the LPS group the glomerular damage score tended to decrease in the LPS + 0,4 API and LPS+ 0,8 API groups, while the tubulointerstitial injury score decreased especially in the LPS + 0,8 API group. In the present study, 0,8 g/kg dose of apilarnil promoted potential renoprotective effects which were achieved, at least in part, by the modulation of important markers of the local immune response in the model of LPS-induced sepsis.
Identifiants
pubmed: 34384831
pii: S0024-3205(21)00862-6
doi: 10.1016/j.lfs.2021.119875
pii:
doi:
Substances chimiques
Biological Products
0
Lipopolysaccharides
0
NF-kappa B
0
Protective Agents
0
Toll-Like Receptor 4
0
apilarnil
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
119875Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.